Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Proc Natl Acad Sci U S A ; 120(6): e2114747120, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36716374

ABSTRACT

Biomolecular condensates, membraneless organelles found throughout the cell, play critical roles in many aspects of cellular function. Ribonucleoprotein granules (RNPs) are a type of biomolecular condensate necessary for local protein synthesis and are involved in synaptic plasticity and long-term memory. Most of the proteins in RNPs possess low-complexity motifs (LCM), allowing for increased promiscuity of protein-protein interactions. Here, we describe the importance of protein-protein interactions mediated by the LCM of RNA-binding protein cytoplasmic polyadenylation element binding protein 3 (CPEB3). CPEB3 is necessary for long-term synaptic plasticity and memory persistence, but the mechanisms involved are still not completely elucidated. We now present key mechanisms involved in its regulation of synaptic plasticity. We find that CPEB3-LCM plays a role in appropriate local protein synthesis of messenger ribonucleic acid (mRNA) targets, through crucial protein-protein interactions that drive localization to neuronal Decapping protein 1 (DCP1)-bodies. Translation-promoting CPEB3 and translation-inhibiting CPEB1 are packaged into neuronal RNP granules immediately after chemical long-term potentiation is induced, but only translation-promoting CPEB3 is repackaged to these organelles at later time points. This localization to neuronal RNP granules is critical for functional influence on translation as well as overall local protein synthesis (measured as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) insertion into the membrane and localization to the synapse). We therefore conclude that protein-protein interaction between the LCM of CPEB3 plays a critical role in local protein synthesis by utilizing neuronal RNP granules.


Subject(s)
Memory, Long-Term , Neurons , Neurons/metabolism , RNA, Messenger/metabolism , Neuronal Plasticity/physiology , RNA-Binding Proteins/metabolism , Cytoplasmic Granules/metabolism
3.
Circulation ; 110(25): 3773-80, 2004 Dec 21.
Article in English | MEDLINE | ID: mdl-15596568

ABSTRACT

BACKGROUND: Sirolimus-eluting stents (SESs) reduce angiographic restenosis in patients with focal, native coronary artery stenoses. This study evaluated the usefulness of SESs in complex native-vessel lesions at high risk for restenosis. METHODS AND RESULTS: Angiographic follow-up at 240 days was obtained in 701 patients with long (15- to 25-mm) lesions in small-diameter (2.5- to 3.5-mm) native vessels who were randomly assigned to treatment with SESs or bare-metal stents (BMSs) in the SIRIUS trial. Quantitative angiographic measurements of minimal lumen diameter and percent diameter stenosis were obtained within the treated segment, within the stent, and within its 5-mm proximal and distal edges. Patients treated with SESs had lower rates of binary (>50% diameter stenosis) angiographic restenosis within the segment (8.9% versus 36.3% with the BMS; P<0.001) and within the stent (3.2% versus 35.4% with the BMS; P<0.001). SESs were associated with significantly less late lumen loss within the treated segment, within the stent, and within its 5-mm proximal and distal edges (all P<0.001). The reduction of restenosis with the SES was consistent in patients at risk for restenosis, including those with small vessels, long lesions, and diabetes mellitus. The frequency of late aneurysms was similar in the 2 groups. CONCLUSIONS: Compared with BMSs, SESs reduced angiographic late lumen loss within the stent and its adjacent 5-mm margins in patients with complex native-vessel lesions.


Subject(s)
Coronary Angiography , Coronary Restenosis/diagnostic imaging , Sirolimus/therapeutic use , Stents , Aged , Aspirin/therapeutic use , Clopidogrel , Coronary Aneurysm/diagnostic imaging , Coronary Aneurysm/epidemiology , Coronary Restenosis/etiology , Coronary Restenosis/prevention & control , Coronary Stenosis/therapy , Diabetes Complications/therapy , Double-Blind Method , Drug Implants , Drug Therapy, Combination , Female , Follow-Up Studies , Heparin/therapeutic use , Humans , Incidence , Male , Middle Aged , Randomized Controlled Trials as Topic , Sirolimus/administration & dosage , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...